Sintilimab Plus FOLFIRI as Second-line Therapy for Patients With HER2-negative Advanced Gastric Cancer
Clinical trial NCT06365008 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06365008
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2036-06-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.